Physician profile
Robert C Phyfer
NPI 1992258461
$7,020.10
in general payments reported to CMS, 2019-2025
21 companies · $215 in 2025
The $215 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,676 · 2020: $243 · 2021: $3,136 · 2022: $776 · 2023: $653 · 2024: $321 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,567.16 | 2019-2025 | Total30, Precision7, Tryptyr |
| Johnson & Johnson Vision Care, INC. | $1,629.05 | 2019-2025 | Acuvue |
| Biotissue Holdings INC. | $1,183.21 | 2021 | |
| Bausch & Lomb Americas INC. | $429.61 | 2022-2025 | Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $347.07 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $144.44 | 2020-2023 | Cequa |
| Oyster Point Pharma, INC. | $86.99 | 2022-2023 | Tyrvaya |
| Coopervision INC. | $81.03 | 2022 | |
| Allergan, INC. | $77.07 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $68.84 | 2024 | Acthar |
| Sight Sciences, INC. | $56.49 | 2023 | Omni Surgical System |
| Lkc Technologies, INC. | $52.01 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $47.75 | 2021-2022 | |
| Dompe US, INC. | $45.86 | 2020-2022 | |
| Abbvie INC. | $43.88 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $40.34 | 2021 | |
| Glaukos Corporation | $35.12 | 2022 | |
| Rxsight INC | $28.36 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Novartis Pharmaceuticals Corporation | $23.43 | 2019-2022 | |
| Spark Therapeutics, INC. | $18.75 | 2022 | |
| Maculogix, INC. | $13.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Phyfer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.